Create Account
Log In
Dark
chart
exchange
Premium
Terminal
Screener
Stocks
Crypto
Forex
Trends
Depth
Close
Check out our API

SDGR
Schrodinger, Inc. Common Stock
stock NASDAQ

At Close
May 22, 2026 3:59:59 PM EDT
13.31USD+0.567%(+0.08)1,322,877
0.00Bid   0.00Ask   0.00Spread
Pre-market
May 22, 2026 9:28:30 AM EDT
13.29USD+0.454%(+0.06)3,688
After-hours
May 22, 2026 4:00:30 PM EDT
13.30USD-0.038%(-0.01)375,098
OverviewOption ChainMax PainOptionsHistoricalExchange VolumeDark Pool LevelsDark Pool PrintsExchangesShort VolumeShort Interest - DailyShort InterestBorrow Fee (CTB)Failure to Deliver (FTD)ShortsTrendsNewsNews
Jan 20, 2022
04:00PM EST  Schrdinger Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)   Business Wire
Jan 18, 2022
06:48AM EST  Schrdinger Announces Acquisition Of XTAL BioStructures   RTTNews
06:47AM EST  Schrdinger Announces Acquisition Of XTAL BioStructures, Inc. For $6M In Cash   Benzinga
06:45AM EST  Schrdinger Announces Acquisition of XTAL BioStructures, Inc.   Business Wire
Jan 5, 2022
04:30PM EST  Schrdinger to Present at H.C. Wainwright BioConnect Conference   Business Wire
Dec 21, 2021
07:13AM EST  Schrdinger Announces Retirement Of Chief Financial Officer Joel Lebowitz   Benzinga
07:12AM EST  Schrdinger CFO Joel Lebowitz To Retire   RTTNews
07:00AM EST  Schrdinger Announces Retirement of Chief Financial Officer Joel Lebowitz   Business Wire
Dec 20, 2021
08:30AM EST  Schrdinger Reports Inducement Grants under Nasdaq Listing Rule 5635(c)(4)   Business Wire
Dec 11, 2021
09:06AM EST  Schrdinger Reports Preclinical Data Supporting Advancement Of Its MALT1 Inhibitor Program at ASH 2021; Data Highlight Strong Anti-Tumor Activity Across Multiple Tumor Models and Combination Potential with Other Agents   Benzinga
Nov 22, 2021
08:30AM EST  Schrdinger to Participate in Five Upcoming Investor Conferences   Business Wire
Nov 19, 2021
11:58AM EST  Expert Ratings For Schrodinger   Benzinga
10:09AM EST  Benzinga's Top Ratings Upgrades, Downgrades For November 19, 2021   Benzinga
06:45AM EST  Morgan Stanley Downgrades Schrodinger to Equal-Weight, Lowers Price Target to $49   Benzinga
04:55AM EST  Piper Sandler Initiates Coverage On Schrodinger with Overweight Rating, Announces Price Target of $87   Benzinga
Nov 18, 2021
07:31AM EST  Schrdinger Awarded $4.9M Grant To Accelerate Drug Discovery In Women's Health   Benzinga
07:00AM EST  Schrdinger Awarded Grant to Accelerate Drug Discovery in Women's Health   Business Wire
Nov 17, 2021
08:30AM EST  Schrdinger Reports Inducement Grants under Nasdaq Listing Rule 5635(c)(4)   Business Wire
Nov 11, 2021
10:01AM EST  Benzinga's Top Ratings Upgrades, Downgrades For November 11, 2021   Benzinga
08:02AM EST  10 Biggest Price Target Changes For Thursday   Benzinga
06:28AM EST  B of A Securities Downgrades Schrodinger to Neutral, Lowers Price Target to $52   Benzinga
Nov 10, 2021
04:16PM EST  Schrodinger Sees FY21 Sales $124M-$134M vs. $138.49M Est.   Benzinga
04:14PM EST  Schrodinger Q3 EPS $(0.49) Misses $(0.43) Estimate, Sales $29.85M Miss $31.58M Estimate   Benzinga
04:01PM EST  Schrdinger Reports Third Quarter 2021 Financial Results and Provides Company Update   Business Wire
04:09AM EST  Earnings Scheduled For November 10, 2021   Benzinga
Nov 9, 2021
08:30AM EST  Schrdinger to Present at Jefferies London Healthcare Conference   Business Wire
Nov 4, 2021
09:05AM EDT  Schrdinger to Present New Preclinical Data From Its MALT1 Inhibitor Program at ASH 2021 Annual Meeting   Business Wire
Oct 29, 2021
08:30AM EDT  Schrdinger to Host Conference Call to Discuss Third Quarter 2021 Financial Results   Business Wire
Oct 18, 2021
08:05AM EDT  Centessa Pharmaceuticals Subsidiary, Orexia Therapeutics, And Schrdinger Announce Collaboration To Discover Novel Orexin Receptor Agonists   Benzinga
08:00AM EDT  00C2Discovery efforts will focus on small molecules with differentiated clinical profiles to harness the broad potential of orexin agonism across different indications~~W0:   GlobeNewswire Inc
08:00AM EDT  Centessa Pharmaceuticals Subsidiary, Orexia Therapeutics, and Schrdinger Announce Collaboration to Discover Novel Orexin Receptor Agonists   Business Wire
07:30AM EDT  Schrdinger Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)   Business Wire
Oct 13, 2021
01:38PM EDT  Benzinga's Top Ratings Upgrades, Downgrades For October 13, 2021   Benzinga
01:38PM EDT  Berenberg Initiates Coverage On Schrodinger with Buy Rating, Announces Price Target of $91   Benzinga
Oct 7, 2021
08:14AM EDT  MD Anderson And Schrdinger Announce Strategic Research Collaboration To Accelerate Development Of WEE1 Program   Benzinga
Sep 22, 2021
08:30AM EDT  Schrdinger Reports Inducement Grants under Nasdaq Listing Rule 5635(c)(4)   Business Wire
Sep 3, 2021
08:31AM EDT  Schrdinger to Present at Four Investor Conferences in September   Business Wire
Sep 1, 2021
03:53PM EDT  Why Schrdinger Shares Are Rising   Benzinga
10:13AM EDT  Benzinga's Top Ratings Upgrades, Downgrades For September 1, 2021   Benzinga
06:07AM EDT  Morgan Stanley Upgrades Schrodinger to Overweight, Announces $82 Price Target   Benzinga
Aug 18, 2021
08:01AM EDT  Schrdinger Reports Inducement Grants under Nasdaq Listing Rule 5635(c)(4)   Business Wire
Aug 12, 2021
10:01AM EDT  Shares of life sciences and materials science company Schrdinger, Inc. (SDGR) are down more than 5% in the morning trade on Thursday following second-quarter results.   RTTNews
07:21AM EDT  Recap: Schrodinger Q2 Earnings   Benzinga
07:18AM EDT  Schrdinger Q2 Revenue $29.8 Mln, 29% Increase   RTTNews
07:12AM EDT  Schrodinger Sees FY21 Sales $124M-$142M Vs. $138.82M Est.   Benzinga
07:11AM EDT  Schrodinger Q2 EPS $(0.49) Misses $(0.33) Estimate, Sales $29.80M Miss $29.88M Estimate   Benzinga
07:01AM EDT  Schrdinger Reports Second Quarter 2021 Financial Results and Provides Company Update   Business Wire
04:14AM EDT  Earnings Scheduled For August 12, 2021   Benzinga
Aug 4, 2021
11:53AM EDT  Schrdinger, Zai Lab Team Up For Cancer Program Targeting DNA Damage Response   Benzinga
07:38AM EDT  Schrdinger And Zai Lab Announce A Global R&D Collaboration In Oncology; Schrdinger Eligible To Receive Up To $338M In Milestone Payments   Benzinga
07:38AM EDT  Schrdinger And Zai Lab Announce Global R&D Collaboration In Oncology   RTTNews
07:30AM EDT  Schrdinger and Zai Lab Announce a Global R&D   GlobeNewswire Inc
Jul 30, 2021
08:01AM EDT  Schrdinger to Host Conference Call to Discuss Second Quarter 2021 Financial Results   Business Wire
Jul 28, 2021
08:01AM EDT  Schrdinger Hosts First Annual Educator's Day and Announces "Teaching with Schrdinger" Program   Business Wire
Jul 16, 2021
08:00AM EDT  Schrdinger Reports Inducement Grants under Nasdaq Listing Rule 5635(c)(4)   Business Wire
Jul 14, 2021
08:02AM EDT  Schrdinger to Present at Two Virtual Investor Conferences in   Business Wire
Jun 17, 2021
04:01PM EDT  Schrdinger Reports Inducement Grants under Nasdaq Listing Rule 5635(c)(4)   Business Wire
09:57AM EDT  Return On Capital Employed Overview: Schrodinger   Benzinga
Jun 2, 2021
09:52AM EDT  Schrodinger Insights: Return On Capital Employed   Benzinga
May 25, 2021
10:02AM EDT  Benzinga's Top Ratings Upgrades, Downgrades For May 25, 2021   Benzinga
08:49AM EDT  Craig-Hallum Initiates Coverage On Schrodinger with Buy Rating, Announces Price Target of $85   Benzinga
08:01AM EDT  Schrdinger to Present at Two Investor Healthcare Conferences   Business Wire
May 19, 2021
08:00AM EDT  Schrdinger Reports Inducement Grants under Nasdaq Listing Rule 5635(c)(4)   Business Wire
May 12, 2021
08:55AM EDT  Morgan Stanley Maintains Equal-Weight on Schrodinger, Lowers Price Target to $83   Benzinga
May 11, 2021
12:47PM EDT  Earnings Scheduled For May 11, 2021   Benzinga
11:03AM EDT  Looking Into Schrodinger's Return On Capital Employed   Benzinga
07:16AM EDT  Recap: Schrodinger Q1 Earnings   Benzinga
07:09AM EDT  Schrdinger Reaffirms FY21 Sales Guidance Of $124M-$142M vs $137.32M Est.   Benzinga
07:08AM EDT  Schrodinger Q1 Adj. EPS $0.00 Beats $(0.16) Est., Sales $32.10M Beat $29.23M Estimate   Benzinga
04:14AM EDT  Earnings Scheduled For May 11, 2021   Benzinga
May 4, 2021
08:01AM EDT  Schrdinger to Present at the Bank of America Securities 2021 Virtual Healthcare Conference   Business Wire
Apr 27, 2021
08:01AM EDT  Schrdinger to Host Conference Call to Discuss First Quarter 2021 Financial Results   Business Wire
Apr 16, 2021
08:00AM EDT  Schrdinger Reports Inducement Grants under Nasdaq Listing Rule 5635(c)(4)   Business Wire
Apr 12, 2021
08:21AM EDT  Schrdinger Reports Preclinical Data On Novel, Selective CDC7 Inhibitors Presented At American Association For Cancer Research Annual Meeting   Benzinga
Apr 9, 2021
08:01AM EDT  Schrdinger to Participate in BMO BioPharma Spotlight Series: Technology-Enabled Drug Discovery   Business Wire
Mar 30, 2021
08:01AM EDT  Schrdinger to Host Webcast in Conjunction with Presentation of Preclinical Data for Its CDC7 Program at Virtual AACR Annual Meeting   Business Wire
Mar 17, 2021
08:01AM EDT  Schrdinger to Participate in Credit Suisse 2021 Healthcare Innovators Series: The Intersection of Drug Discovery, Drug Development and Artificial Intelligence   Business Wire
Mar 10, 2021
04:47PM EST  Schrodinger Announces Preclinical Data for CDC7 Program To Be Presented At Virtual Annual Meeting 2021   Benzinga
Mar 4, 2021
02:52PM EST  Mid-Afternoon Market Update: Nasdaq Tumbles Over 200 Points; Five Prime Therapeutics Shares Spike Higher   Benzinga
12:26PM EST  Mid-Day Market Update: Dow Turns Positive; Schrdinger   Benzinga
09:45AM EST  Shares of Schrdinger, Inc. (SDGR) are losing nearly 25% on Thursday morning after the company reported fourth-quarter results.   RTTNews
07:07AM EST  Schrodinger Sees FY21 Sales $124M-$142M Vs. $177.25M Est.   Benzinga
07:06AM EST  Schrodinger Q4 Sales $33.00M Miss $37.87M Estimate   Benzinga
04:07AM EST  Earnings Scheduled For March 4, 2021   Benzinga
Mar 1, 2021
08:01AM EST  Schrdinger to Present at the H.C. Wainwright Global Life Sciences Conference   Business Wire
Feb 25, 2021
08:21AM EST  Schrodinger Reports Expansion Of Deal With Google Cloud   Benzinga
08:01AM EST  Schrdinger Expands Agreement with Google Cloud to Further Bolster Its Drug Discovery and Materials Science Initiatives   Business Wire
Feb 19, 2021
08:01AM EST  Schrdinger to Present at the SVB Leerink Partners 10th Annual Global Healthcare Conference   Business Wire
Feb 18, 2021
08:01AM EST  Schrdinger to Host Conference Call to Discuss Fourth Quarter and Year-End 2020 Financial Results   Business Wire
Feb 11, 2021
11:21AM EST  Stocks That Hit 52-Week Highs On Thursday   Benzinga
Dec 7, 2020
07:18AM EST  SchrdingerPresents Data From Its MALT1 Inhibitor Program At The ASH 2020 Annual Meeting   RTTNews
07:01AM EST  Schrdinger Presents Data from Its MALT1 Inhibitor Program at the American Society of Hematology (ASH) 2020 Annual Meeting   Business Wire
Nov 23, 2020
11:36AM EST  Why Schrodinger's Stock Is Trading Higher Today   Benzinga
10:45AM EST  Looking Into Schrodinger's Return On Capital Employed   Benzinga
10:36AM EST  B of A Securities Upgrades Schrodinger to Buy, Announces $74 Price Target   Benzinga
10:06AM EST  Schrdinger Up 10% On Tie-up With Bristol Myers   RTTNews
06:54AM EST  Schrdinger, Inc. (SDGR) said Monday it has entered into a multi-year discovery collaboration with Bristol Myers Squibb Co. (BMY) to discover, develop, and commercialize therapeutics in multiple disease areas.   RTTNews
06:36AM EST  Schrdinger Announces Discovery Collaboration With Bristol Myers Squibb   RTTNews
06:32AM EST  Schrdinger Announces a Multi-Target Drug Discovery, Development, and Commercialization Collaboration with Bristol Myers Squibb; Schrdinger To Receive $55M Upfront And Is Eligible To Receive $2.7B In Milestone Payments Plus Royalties   Benzinga
06:30AM EST  Schrdinger Announces a Multi-Target Drug Discovery, Development, and Commercialization Collaboration with Bristol Myers Squibb   Business Wire
Nov 13, 2020
08:18AM EST  Morgan Stanley Maintains Equal-Weight on Schrodinger, Lowers Price Target to $89   Benzinga
Nov 12, 2020
02:48PM EST  Schrdinger, Inc. Reports Third Quarter 2020 Financial Results and Business Update   Business Wire
08:55AM EST  Yahoo Finance Trending Stocks For Thursday, Nov. 12, 2020: XPEV, PDD, MRNA, PLTR, LI, IMAC, HYLN, EDRY, MPLN, WIX, SINO, VRM, PLUG, BLNK, UPS, BNGO, GRWG, PXS, FOSL, WWR, JD, NOW, IDEX, HIMX, INMD, NNDM, SDGR, TELL, RVLV   Benzinga
07:39AM EST  Schrdinger Q3 Net Income After Adjusting For Non-controlling Interests $3.9 Mln Vs. Net Loss $11.5 Mln Last Year   RTTNews
07:06AM EST  Schrodinger Q3 EPS $0.05 Beats $(0.07) Estimate, Sales $25.80M Beat $23.03M Estimate   Benzinga
07:00AM EST  Schrdinger, Inc. Reports Third Quarter 2020 Financial Results and Business Update   Business Wire
04:18AM EST  Earnings Scheduled For November 12, 2020   Benzinga
Nov 10, 2020
07:00AM EST  Schrdinger to Present at Upcoming Investor Conferences   Business Wire
Nov 5, 2020
07:00AM EST  Schrdinger to Present Data from Its MALT1 Inhibitor Program at the American Society of Hematology (ASH) 2020 Annual Meeting   Business Wire
07:00AM EST  Schrdinger to Host Third Quarter 2020 Financial Results Conference Call and Webcast   Business Wire
Oct 13, 2020
02:23PM EDT  Why Schrodinger's Stock Is Trading Lower Today   Benzinga
10:19AM EDT  Morgan Stanley Maintains Equal-Weight on Schrodinger, Lowers Price Target to $90   Benzinga
Oct 12, 2020
09:47AM EDT  Benzinga's Top Upgrades, Downgrades For October 12, 2020   Benzinga
09:26AM EDT  Jefferies Upgrades Schrodinger to Buy, Raises Price Target to $75   Benzinga
Sep 25, 2020
11:25AM EDT  Cramer Gives His Opinion On BioXcel, Schrodinger And More   Benzinga
Sep 8, 2020
07:00AM EDT  Schrdinger to Present at the Morgan Stanley 18th Annual Global Healthcare Conference   Business Wire
Aug 17, 2020
04:30PM EDT  Schrdinger Announces Closing of Public Offering   Business Wire
Aug 13, 2020
12:08PM EDT  ROCE Insights For Schrodinger   Benzinga
Aug 12, 2020
10:10PM EDT  Schrdinger Announces Pricing Of Underwritten Public Offering Of 5 Mln Shares At $66/shr   RTTNews
10:00PM EDT  Schrdinger Announces Pricing of Public Offering   Business Wire
Aug 10, 2020
04:37PM EDT  Schrdinger Announces Proposed 4.5M Share Public Offering Of Common Stock   Benzinga
04:08PM EDT  Schrdinger Announces Proposed Public Offering of Common Stock   Business Wire
06:16AM EDT  Schrodinger Q2 EPS $(0.05) Beats $(0.28) Estimate, Sales $23.09M Beat $17.93M Estimate   Benzinga
06:14AM EDT  Schrdinger Q2 Net Loss $3.4 Mln Vs Loss Of $0.5 Mln Last Year   RTTNews
06:00AM EDT  Schrdinger, Inc. Reports Second Quarter 2020 Financial Results and Business Updates   Business Wire
04:10AM EDT  Earnings Scheduled For August 10, 2020   Benzinga
Aug 3, 2020
07:02AM EDT  Schrdinger to Host Second Quarter 2020 Financial Results Conference Call and Webcast   Business Wire
Jul 28, 2020
07:14AM EDT  Schrodinger Reports Strategic Collaboration With Viva Biotech To Generate, Interrogate Structures For Unsolved Targets, No Terms Disclosed   Benzinga
07:00AM EDT  Schrdinger and Viva Biotech Announce Strategic Collaboration to Generate and Interrogate Structures for Unsolved Targets   Business Wire
Jul 15, 2020
10:52AM EDT  Morgan Stanley Maintains Equal-Weight on Schrodinger, Raises Price Target to $93   Benzinga


Share
About
Pricing
Policies
Markets
API
Info
tz UTC-4
Connect with us
ChartExchange Email
ChartExchange on Discord
ChartExchange on X
ChartExchange on Reddit
ChartExchange on GitHub
ChartExchange on YouTube
© 2020 - 2026 ChartExchange LLC